Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
drugs
fda
indiana blog main
indiana top stories
2
×
jefferies
2
×
life sciences
2
×
national
national blog main
national top stories
new york blog main
2
×
new york top stories
raleigh-durham blog main
2
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
age related macular degeneration
agios pharmaceuticals
alder biopharmaceutical
allergan
american academy of neurology
american society of hematology
amgen
atogepant
beta-thalassemia
biohaven
What
big
meeting
american
approval
arguments
ash
blood
class
commercialized
companies
competitors
country
decades
diego
disease
drug
drugs
fda
gathering
hematology’s
largest
make
medical
migraine
neuro
new
oral
potential
previewed
rolls
san
society
therapies
week
won
xconomy
year
Language
Current search:
jefferies
×
" life sciences "
×
" new york blog main "
×
" indiana top stories "
×
" raleigh-durham blog main "
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On